402 related articles for article (PubMed ID: 10672058)
21. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
23. In situ detection of activated cytotoxic cells in follicular lymphomas.
Leger-Ravet MB; Devergne O; Peuchmaur M; Solal-Celigny P; Brousse N; Gaulard P; Galanaud P; Emilie D
Am J Pathol; 1994 Mar; 144(3):492-9. PubMed ID: 7510456
[TBL] [Abstract][Full Text] [Related]
24. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
Tomaszewski MM; Lupton GP; Krishnan J; May DL
J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
[TBL] [Abstract][Full Text] [Related]
25. Non-cytotoxic gamma-delta peripheral T-cell lymphoma affecting the mandibular and parotidal lymph nodes and the skin.
Lima M; Canelhas A; Santos C; dos Anjos Teixeira M; Coutinho J; Alves R; Queirós ML; Fonseca S; Santos AH; Gonçalves V; Massa A; Justiça B
Leuk Lymphoma; 2003 Mar; 44(3):525-9. PubMed ID: 12688326
[TBL] [Abstract][Full Text] [Related]
26. Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity.
Mukai HY; Hasegawa Y; Kojima H; Okoshi Y; Takei N; Yamashita Y; Nagasawa T; Mori N
Mod Pathol; 2002 Nov; 15(11):1131-9. PubMed ID: 12429791
[TBL] [Abstract][Full Text] [Related]
27. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
[TBL] [Abstract][Full Text] [Related]
28. Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
Harvell J; Vaseghi M; Natkunam Y; Kohler S; Kim Y
J Cutan Pathol; 2002 Feb; 29(2):88-92. PubMed ID: 12150138
[TBL] [Abstract][Full Text] [Related]
29. Absence of cytotoxic molecules in CD8- and/or CD56-positive adult T-cell leukaemia/lymphoma.
Ohshima K; Haraoka S; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):101-4. PubMed ID: 10599307
[TBL] [Abstract][Full Text] [Related]
30. Intratumoral activation of CD8-positive cytotoxic lymphocytes in acquired immunodeficiency syndrome lymphomas.
Devergne O; Raphael M; Autran B; Leger-Ravet MB; Coumbaras J; Crevon MC; Galanaud P; Emilie D
Hum Pathol; 1995 Mar; 26(3):284-90. PubMed ID: 7890279
[TBL] [Abstract][Full Text] [Related]
31. Expression of granzyme B, perforin and TIA-1 in urine lymphocytes: noninvasive monitoring of renal transplant function.
Barth C; Rodermann E; Stachowski J; Herzog R; Rohde S; Baldamus CA
Transplant Proc; 1998 Aug; 30(5):2347. PubMed ID: 9723498
[No Abstract] [Full Text] [Related]
32. Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides.
Mitteldorf C; Robson A; Tronnier M; Pfaltz MC; Kempf W
Dermatology; 2015; 231(2):164-70. PubMed ID: 26111483
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous CD30(+) lymphoproliferative disorders.
Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
[TBL] [Abstract][Full Text] [Related]
35. Expression of cytotoxic molecules in intestinal T-cell lymphomas. The German Study Group on Intestinal Non-Hodgkin Lymphoma.
Daum S; Foss HD; Anagnostopoulos I; Dederke B; Demel G; Araujo I; Riecken EO; Stein H
J Pathol; 1997 Jul; 182(3):311-7. PubMed ID: 9349234
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
37. Recurrent course and CD30 expression of atypical T lymphocytes distinguish lymphomatoid papulosis from primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma.
Tsujiwaki M; Abe R; Ohguchi Y; Hoshina D; Murata J; Fujita Y; Nomura T; Ambo M; Shimizu H
Acta Derm Venereol; 2014 Sep; 94(5):613-4. PubMed ID: 24549273
[No Abstract] [Full Text] [Related]
38. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
Collins K; Gu J; Aung PP; Nagarajan P; Curry JL; Huen A; Ivan D; Prieto VG; Tetzlaff MT; Duvic M; Miranda RN; Vega F; Torres-Cabala CA
Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
[TBL] [Abstract][Full Text] [Related]
39. Lymphomatoid papulosis histopathologically simulating angiocentric and cytotoxic T-cell lymphoma: a case report.
Wu WM; Tsai HJ
Am J Dermatopathol; 2004 Apr; 26(2):133-5. PubMed ID: 15024196
[TBL] [Abstract][Full Text] [Related]
40. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?
Ng CS; Lo ST; Chan JK; Chan WC
Hum Pathol; 1997 Nov; 28(11):1276-82. PubMed ID: 9385933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
